Uh Oh, We've Lost That Page!
We're sorry...
You'll probably be able to find what you want by visiting the Home page. We'll try not to let that happen again.
New Stories
-
Arovella advances ALA-101 program with CRO appointment and Phase 1 trial preparations
October 29, 2025 - - Latest News -
Australian-based world-first RNA trial offers new hope for lupus patients
October 29, 2025 - - Latest News -
DurAVR delivers strong one-year results for patients with small aortic annuli
October 29, 2025 - - Latest News -
Australia launches first clinical and commercial-scale viral vector manufacturing facility
October 29, 2025 - - Latest News -
Uniseed names Alastair Hick as new CEO to lead next phase of growth
October 29, 2025 - - Latest News -
Advisory committee backs Avita's burns treatment, paving the way for expanded access in Australia
October 29, 2025 - - Latest News -
Myrio Therapeutics partners with leading US research institutions to advance T cell immunotherapies for solid tumours
October 28, 2025 - - Latest News